Mode
Text Size
Log in / Sign up
N/A N=40 Randomized Single-blind Treatment

Clinical and Microbiologic Outcomes of Adjunctive Antimicrobial Photodynamic Therapy in the Non-surgical and Surgical Treatment of Teeth With Periodontal Disease

Periodontal Diseases

Enrolled (actual)
40
Serious AEs
0.0%
Results posted
Mar 2026
Primary outcome: Primary: Change in Number of Bleeding Sites (Bleeding On Probing) — -1.60; -1.40 bleeding sites

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
mechanical debridement (Device); adjunctive aPDT (Device); sham aPDT (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
The University of Texas Health Science Center, Houston
Primary completion
Oct 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Number of Bleeding Sites (Bleeding On Probing)
-1.40; -1.80
PRIMARY
Change in Number of Bleeding Sites (Bleeding On Probing)
-1.40; -1.80
PRIMARY
Change in Probing Depth (Periodontal Pocket Depth )
-0.03; -0.60
PRIMARY
Change in Probing Depth (Periodontal Pocket Depth )
-0.03; -0.60
SECONDARY
Microbiologic Profile of Plaque as Indicated by Percent of Total Abundance of 4 Oral Bacterial Complexes
2.52; 2.98; 13.62; 12.00; 1.81; 2.21
SECONDARY
Microbiologic Profile of Plaque as Indicated by Percent of Total Abundance of 4 Oral Bacterial Complexes
2.52; 2.98; 13.62; 12.00; 1.81; 2.21
SECONDARY
Microbiologic Profile of Plaque as Indicated by Percent of Total Abundance of 4 Oral Bacterial Complexes
2.52; 2.98; 13.62; 12.00; 1.81; 2.21
SECONDARY
Change in Microbiologic Profile of Gingival Crevicular Fluid(GCF)

Summary

The purpose of this study is to compare clinical outcomes after mechanical debridement of at sites exhibiting plaque induced inflammation with or without adjunctive Antimicrobial photodynamic therapy (aPDT) and to assess the the microbiologic profile before and after treatment with or without aPDT

Eligibility Criteria

Inclusion Criteria

  • One pocket on each side of the mouth (split design)
  • Single rooted tooth
  • Pocket depths measured greater than 4mm with bleeding on probing
  • Horizontal bone loss
  • No furcation involvement

Exclusion Criteria

  • current heavy smokers (>10 cigarettes/day)
  • have uncontrolled diabetes (HbA1c ≥ 6.5%)
  • other uncontrolled systemic diseases that may comprise healing, such as Vitamin C deficiency, any neutrophil deficiencies, immunodeficiency syndromes, or leukemia
  • taking antibiotics within 3 months before the procedure
  • vertical bone defects that requires surgical regenerative treatment.
  • Pregnancy
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05252000). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search